Li, T., Wu, R., & Luo, K. Q. PCSK9 Promotes the Malignancy of Triple‐negative Breast Cancer Cells by Reducing Cholesterol Levels at the Plasma Membrane to Activate EGFR and HER3. Wiley.
Chicago Style (17th ed.) CitationLi, Tianhong, Renfei Wu, and Kathy Qian Luo. PCSK9 Promotes the Malignancy of Triple‐negative Breast Cancer Cells by Reducing Cholesterol Levels at the Plasma Membrane to Activate EGFR and HER3. Wiley.
MLA (9th ed.) CitationLi, Tianhong, et al. PCSK9 Promotes the Malignancy of Triple‐negative Breast Cancer Cells by Reducing Cholesterol Levels at the Plasma Membrane to Activate EGFR and HER3. Wiley.
Warning: These citations may not always be 100% accurate.